世界科学技术-中医药现代化
世界科學技術-中醫藥現代化
세계과학기술-중의약현대화
WORLD SCIENCE AND TECHNOLOGY-MODERNIZATION OF TRADITIONAL CHINESE MEDICINE
2014年
11期
2406-2410
,共5页
刁建新%马文校%刘亚伟%华何与%杨运高
刁建新%馬文校%劉亞偉%華何與%楊運高
조건신%마문교%류아위%화하여%양운고
D-氨基半乳糖%脂多糖%急性肝衰竭%丙氨酸氨基转移酶%天门冬氨酸氨基转移酶
D-氨基半乳糖%脂多糖%急性肝衰竭%丙氨痠氨基轉移酶%天門鼕氨痠氨基轉移酶
D-안기반유당%지다당%급성간쇠갈%병안산안기전이매%천문동안산안기전이매
D-galactosamine%lipopolysaccharide%acute liver failure%ALT%AST
目的:观察不同剂量D-氨基半乳糖(D-GalN)联合脂多糖(LPS)对大鼠急性肝衰竭模型的影响及凝血功能的变化,建立理想的急性肝衰竭大鼠模型。方法:SD大鼠随机分为正常组,D-GalN高、中、低剂量组,每组10只,除正常组外,其余各组注射不同剂量D-GalN联合LPS建立急性肝衰竭大鼠模型,观察大鼠的死亡率,检测大鼠0、12、24、48、72 h肝功能及凝血功能的水平;HE染色,观察肝脏病理的变化。结果:D-GalN高、中、低剂量组72 h内的死亡率分别为:60%、30%、10%;不同剂量组不同时间点血液中丙氨酸氨基转移酶(ALT)、天门冬氨酸氨基转移酶(AST)、总胆红素(TBIL)、凝血酶原时间(PT)、国际标准比率(INR)、血浆纤维蛋白原(FIB)含量与正常组比较均有明显差异(P<0.05);但在高、中、低剂量组间比较, ALT、AST无统计学意义,TBIL、PT、INR、FIB均有统计学差异(P<0.05)。结论:凝血功能在肝衰竭模型建立中为更加稳定的检测指标,通过肝功能、凝血功能、病理形态综合诊断,中剂量D-GalN联合LPS腹腔注射48 h后建立的急性肝衰竭大鼠模型与临床肝衰竭症状比较一致,中剂量是理想的造模剂量。
目的:觀察不同劑量D-氨基半乳糖(D-GalN)聯閤脂多糖(LPS)對大鼠急性肝衰竭模型的影響及凝血功能的變化,建立理想的急性肝衰竭大鼠模型。方法:SD大鼠隨機分為正常組,D-GalN高、中、低劑量組,每組10隻,除正常組外,其餘各組註射不同劑量D-GalN聯閤LPS建立急性肝衰竭大鼠模型,觀察大鼠的死亡率,檢測大鼠0、12、24、48、72 h肝功能及凝血功能的水平;HE染色,觀察肝髒病理的變化。結果:D-GalN高、中、低劑量組72 h內的死亡率分彆為:60%、30%、10%;不同劑量組不同時間點血液中丙氨痠氨基轉移酶(ALT)、天門鼕氨痠氨基轉移酶(AST)、總膽紅素(TBIL)、凝血酶原時間(PT)、國際標準比率(INR)、血漿纖維蛋白原(FIB)含量與正常組比較均有明顯差異(P<0.05);但在高、中、低劑量組間比較, ALT、AST無統計學意義,TBIL、PT、INR、FIB均有統計學差異(P<0.05)。結論:凝血功能在肝衰竭模型建立中為更加穩定的檢測指標,通過肝功能、凝血功能、病理形態綜閤診斷,中劑量D-GalN聯閤LPS腹腔註射48 h後建立的急性肝衰竭大鼠模型與臨床肝衰竭癥狀比較一緻,中劑量是理想的造模劑量。
목적:관찰불동제량D-안기반유당(D-GalN)연합지다당(LPS)대대서급성간쇠갈모형적영향급응혈공능적변화,건립이상적급성간쇠갈대서모형。방법:SD대서수궤분위정상조,D-GalN고、중、저제량조,매조10지,제정상조외,기여각조주사불동제량D-GalN연합LPS건립급성간쇠갈대서모형,관찰대서적사망솔,검측대서0、12、24、48、72 h간공능급응혈공능적수평;HE염색,관찰간장병리적변화。결과:D-GalN고、중、저제량조72 h내적사망솔분별위:60%、30%、10%;불동제량조불동시간점혈액중병안산안기전이매(ALT)、천문동안산안기전이매(AST)、총담홍소(TBIL)、응혈매원시간(PT)、국제표준비솔(INR)、혈장섬유단백원(FIB)함량여정상조비교균유명현차이(P<0.05);단재고、중、저제량조간비교, ALT、AST무통계학의의,TBIL、PT、INR、FIB균유통계학차이(P<0.05)。결론:응혈공능재간쇠갈모형건립중위경가은정적검측지표,통과간공능、응혈공능、병리형태종합진단,중제량D-GalN연합LPS복강주사48 h후건립적급성간쇠갈대서모형여림상간쇠갈증상비교일치,중제량시이상적조모제량。
This study was aimed to observe effects of different doses of D-galactosamine (D-GalN) plus lipopoly-saccharide (LPS) and blood coagulation changes among rat model of acute liver failure, in order to establish an ideal model of acute liver failure in rats. SD rats were randomly divided into the control group, D-GalN high, medium and low dose groups, with 10 rats in each group. Except the normal group, rats in other groups were injected with D-GalN plus LPS at different doses to induce acute liver failure. The mortality of rats was observed. The liver function and blood coagulation were detected from rat serum at 0 h, 12 h, 24 h, 48 h, and 72 h. HE stain was used in the observa-tion of changes on liver pathological changes. The results showed that the mortality of D-GalN high, medium and low dose groups within 72 h were 60%, 30%, 10%, respectively. There were significant differences on the serum content level of ALT, AST, TBIL, PT, INR, FIB from different dose groups at different time points and the normal group (P<0.05). However, the comparison among D-GalN high, medium and low dose groups showed no statistical difference on ALT and AST; while there were statistical differences on TBIL, PT, INR and FIB (P < 0.05). It was concluded that coagulation index was more stable in the liver failure model. Through observation on the liver function, blood coagulation and pathological morphology, the model of acute liver failure induced with medium dose of D-GalN plus LPS in SD rats at 48 h was more similar to the clinical symptom of acute liver failure. Therefore, the medium dose was the ideal model inducing dose.